Table 2.
Showing the number and percentage of patients on glaucoma medication and mean values±SD of mean deviation (MD) and pattern SD (PSD) of patients in the groups of ocular hypertension (OHT), high-tensions glaucoma (HTG) and normal-tension glaucoma (NTG)
| OHT | HTG | NTG | P value | |
| Prostaglandin analogues | 31 (58.5%) | 37 (78%) | 23 (69.7%) | 0.260 |
| β-blockers | 7 (13.2%) | 20 (42.5%) | 11 (30.5%) | 0.058 |
| CA-inh | 5 (9.4%) | 17 (36.1%) | 10 (27.7%) | 0.053 |
| α agonist | 3 (5.7%) | 4 (8.5%) | 1 (2.8%) | 0.837 |
| Mean Deviation | −1.46±1.90 | −7.60±8.45 | −6.79±6.28 | <0.001 |
| Post hoc p value | <0.001 | 1.000 | ||
| Pattern Standard Deviation | 1.99±1.36 | 8.40±10.75 | 6.58±3.88 | <0.001 |
| Post hoc p value | <0.001 | 0.199 |
P values express the difference between the groups. When applicable post hoc p values are between NTG and the other groups.
CA-inh, carbonic anhydrase inhibitors.